{"entity":{"type":"insider","cik":"0001864159","url":"/insider/0001864159","json_url":"/insider/0001864159.json","name":"Meyer Andrew Hollman","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":10,"first":"2024-09-27","last":"2026-01-02","span_basis":"filed_date"},"name_variants":[{"name":"Meyer Andrew Hollman","source":"filing","n_filings":10,"first_seen":"2024-09-27","last_seen":"2026-01-02"}],"transactions":[{"id":5792275,"accession":"0001864159-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001864159-26-000002","line_url":"/filing/0001864159-26-000002#line-1","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1879.0,"shares_display":"1,879","price_per_share":13.73,"price_display":"13.73","price_state":"stated","total_value":25798.67,"total_display":"25,798.67","total_whole":"25,799","shares_owned_after":83095.0,"shares_owned_after_display":"83,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-02","scope":"insider"},{"id":4517894,"accession":"0001864159-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001864159-25-000006","line_url":"/filing/0001864159-25-000006","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":32.98202673267327,"price_display":"32.98","price_state":"stated","total_value":109929.0951,"total_display":"109,929.10","total_whole":"109,929","shares_owned_after":85607.0,"shares_owned_after_display":"85,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":5221377,"accession":"0001864159-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001864159-25-000005","line_url":"/filing/0001864159-25-000005#line-2","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":99990.0,"total_display":"99,990.00","total_whole":"99,990","shares_owned_after":84974.0,"shares_owned_after_display":"84,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-14","scope":"insider"},{"id":4447371,"accession":"0001864159-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001864159-25-000003","line_url":"/filing/0001864159-25-000003#line-3","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16665.0,"shares_display":"16,665","price_per_share":30.0622,"price_display":"30.06","price_state":"stated","total_value":500986.563,"total_display":"500,986.56","total_whole":"500,987","shares_owned_after":82139.0,"shares_owned_after_display":"82,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":4074642,"accession":"0001415889-25-011874","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-011874","line_url":"/filing/0001415889-25-011874","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":32.02656786678668,"price_display":"32.03","price_state":"stated","total_value":106744.5507,"total_display":"106,744.55","total_whole":"106,745","shares_owned_after":82539.0,"shares_owned_after_display":"82,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-02","scope":"insider","n_lines":2},{"id":4036275,"accession":"0001415889-25-011243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-011243","line_url":"/filing/0001415889-25-011243#line-2","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":100020.0,"total_display":"100,020.00","total_whole":"100,020","shares_owned_after":82139.0,"shares_owned_after_display":"82,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-21","filed_date":"2025-04-23","scope":"insider"},{"id":5003400,"accession":"0001415889-25-007104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-007104","line_url":"/filing/0001415889-25-007104","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":32.145884613077385,"price_display":"32.15","price_state":"stated","total_value":107174.3793,"total_display":"107,174.38","total_whole":"107,174","shares_owned_after":83040.0,"shares_owned_after_display":"83,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider","n_lines":2},{"id":4074259,"accession":"0001415889-25-003165","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-003165","line_url":"/filing/0001415889-25-003165","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":42.291351409718054,"price_display":"42.29","price_state":"stated","total_value":140999.3656,"total_display":"140,999.37","total_whole":"140,999","shares_owned_after":83055.0,"shares_owned_after_display":"83,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider","n_lines":3},{"id":4317825,"accession":"0001415889-25-000554","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-25-000554","line_url":"/filing/0001415889-25-000554","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13334.0,"shares_display":"13,334","price_per_share":54.88114954252288,"price_display":"54.88","price_state":"stated","total_value":731785.248,"total_display":"731,785.25","total_whole":"731,785","shares_owned_after":86783.0,"shares_owned_after_display":"86,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-03","scope":"insider","n_lines":5},{"id":2257129,"accession":"0001415889-24-024078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-024078","line_url":"/filing/0001415889-24-024078#line-2","is_derivative":false,"issuer_cik":"0001817713","issuer_name":"Janux Therapeutics, Inc.","issuer_ticker":"JANX","issuer_name_source":null,"issuer_url":"/issuer/0001817713","owner_cik":"0001864159","owner_name":"Meyer Andrew Hollman","owner_display_name":"Meyer Andrew Hollman","owner_url":"/insider/0001864159","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":45.9551,"price_display":"45.96","price_state":"stated","total_value":2297755.0,"total_display":"2,297,755.00","total_whole":"2,297,755","shares_owned_after":67592.0,"shares_owned_after_display":"67,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-09-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Officer (Chief Business Officer)","n_filings":10,"first_seen":"2024-09-27","last_seen":"2026-01-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001864159","retrieved_at":"2026-08-22T15:51:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}